Abstract:Objective: The majority of patients with COVID-19 showed mild symptoms. However, approximately 5% of them were critically ill and require intensive care unit admission for advanced life supports. Patients in the intensive care unit were high risk for venous thromboembolism and hemorrhage due to the immobility and anticoagulants used during advanced life supports. The aim of the study was to report the incidence and treatments of the two complications in such patients. Method: Patients with COVID-19 (Group 1) and patients with community-acquired pneumonia (Group 2) that required intensive care unit admission were enrolled in this retrospective study. Their demographics, laboratory results, ultrasound findings and complications such as venous thromboembolism and hemorrhage were collected and compared. Results: Thirty-four patients with COVID-19 and 51 patients with community-acquired pneumonia were included. The mean ages were 66 and 63 years in Groups 1 and 2, respectively. Venous thromboembolism was detected in 6 (18%) patients with COVID-19 and 18 (35%) patients with community-acquired pneumonia (P = 0.09). The major type was distal deep venous thrombosis. Twenty-one bleeding events occurred in 12 (35%) patients with COVID-19 and 5 bleeding events occurred in 5 (10%) patients with community-acquired pneumonia, respectively (P = 0.01). Gastrointestinal system was the most common source of bleeding. With the exception of one death due to intracranial bleeding, blood transfusion with or without surgical/endoscopic treatments was able to manage the bleeding in the remaining patients. Multivariable logistic regression showed increasing odds of hemorrhage with extracorporeal membrane oxygenation (odds ratio: 13.9, 95% confidence interval: 4.0–48.1) and COVID-19 (odds ratio: 4.7, 95% confidence interval: 1.2–17.9). Conclusion: Venous thromboembolism and hemorrhage were common in both groups. The predominant type of venous thromboembolism was distal deep venous thrombosis, which presented a low risk of progression. COVID-19 and extracorporeal membrane oxygenation were risk factors for hemorrhage. Blood transfusion with or without surgical/endoscopic treatments was able to manage it in most cases.

Hemocoagulase Might Not Control but Worsen Gastrointestinal Bleeding in an Elderly Patient with Type II Respiratory Failure

Clinical Features and Endoscopic Treatment for Aged Patients with Acute Hemorrhage Arising from Vascular Malformation of Colon

Incidence, clinical features, and risk factors of hemocoagulase-induced hypofibrinogenemia: A retrospective real-world study

Hemorrhage and Venous Thromboembolism in Critically Ill Patients with COVID-19

Upper Gastrointestinal Hemorrhage In Acute-On-Chronic Liver Failure: Prevalence, Characteristics, And Impact On Prognosis

Hemocoagulase Agkistrodon Can Prevent Bleeding and Induce Hypofibrinogenemia in Hepatic Disease Cases

Successful management of massive gastrointestinal bleeding using recombinant factor Ⅶa in an elderly patient with respiratory and renal failure

Effect of bydroxyethyl starch with different degrees of substitution on expression of platelet membrane glycoprotein

[Risk Factors Associated with Failure from Endoscopic Therapy in Acute Non-Variceal Upper Gastrointestinal Bleeding].

The efficacy and safety of recombinant activated factor Ⅶ on uncontrolled perioperative hemorrhage in elderly patients

Effects of agkistrodon hemocoagulase on coagulation function in patients undergoing cardiac valve replacement with cardiopulmonary bypass

Severe Coagulation Dysfunction caused by Vitamin K Deficiency in an Elderly Patient

Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis

Effects of Acute Hypervolemic Fluid Infusion of Hydroxyethyl Starch and Gelatin on Hemostasis and Possible Mechanisms

Stress-related Upper Gastrointestinal Bleeding in Adult Neurocritical Care Patients: a Chinese Multicenter, Retrospective Study

Efficacy and safety of endoscopic hemocoagulase spray in patients with active gastrointestinal bleeding

Clinical value of endoscopic hemostasis in acute nonvariceal upper gastrointestinal bleeding]

The impact of early gastroscopy examination on cardiovascular event-related indices in elderly patients with acute upper gastrointestinal bleeding

Adjuncts to Blood Component Therapies for the Treatment of Bleeding in the Intensive Care Unit

Salvage treatment for severe upper gastrointestinal bleeding caused by Mallory-Weiss syndrome and myocardial depression after acute myocardial infarction

Clinical features and etiology analysis of upper gastrointestinal bleeding in elderly patients